Home > Healthcare > Medical Services > Cell & Gene Therapy Clinical Trial Services Market
Cell & Gene Therapy Clinical Trial Services Market Size
- Report ID: GMI9355
- Published Date: May 2024
- Report Format: PDF
Cell and Gene Therapy Clinical Trial Services Market Size
Cell And Gene Therapy Clinical Trial Services Market size was valued at USD 4 billion in 2023 growing at a CAGR of 10.8% between 2024 and 2032, driven by factors such as the growing prevalence of chronic and genetic diseases that have created a strong demand for innovative treatment options like cell and gene therapies, leading to a greater number of clinical trials being conducted.
Moreover, the ongoing advancement in the field of biotechnology and gene editing technologies have significantly increased the efficiency and effectiveness of cell and gene therapies, that leads to a greater number of companies investing in clinical trials to test new treatments, thus, driving the market growth. For instance, in November 2023, AstraZeneca announced a collaboration and investment agreement with Cellectis, a clinical-stage biotechnology company, to accelerate the development of next generation therapeutics in areas of high unmet need, including oncology, immunology and rare diseases.
Under the terms of the collaboration agreement, AstraZeneca leverage the Cellectis proprietary gene editing technologies and manufacturing capabilities, to design novel cell and gene therapy products, strengthening AstraZeneca’s growing offering in this space. Therefore, this increase in the number of research & development activities in the field of gene editing will increase the demand for clinical trials services that propel the growth of the market.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Cell & Gene Therapy Clinical Trial Services Market Size in 2023: | USD 4 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 10.8% |
| 2032 Value Projection: | USD 9.8 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 209 |
| Tables, Charts & Figures: | 340 |
| Segments covered: | Service, Phase, Indication, Therapy Type, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
The cell and gene therapy clinical trial services market refers to the sector within the healthcare industry that provides services specifically tailored to support clinical trials for cell therapy and gene therapy treatments. Clinical trials are essential for testing the safety and efficacy of new cell and gene therapy treatments before they can be approved for widespread clinical use. Companies specializing in cell and gene therapy clinical trial services offer a range of services including patient recruitment, study design, regulatory compliance, manufacturing support, data management, and monitoring to facilitate the successful execution of these trials.
Frequently Asked Questions (FAQ) :
Cell & Gene Therapy Clinical Trial Services Market Scope
